Mechanistic insights into how B7x-mediated immune evasion drives resistance to PD-1/PD-L1 blockade in bladder cancer ...
Tolododekin alfa (ANK-101) is a novel anchored immunotherapy that links interleukin-12 (IL-12) to aluminum hydroxide via an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results